Schedule 13G ownership disclosure

Cartesian Therapeutics Inc

COMMON-STOCK · CUSIP: 816212302

Event date: 2026-09-30

Filing-level shares
7,233
Percent of class
0.02%
  • Barclays PLC

    Shares: 7,233 · Class: 0.02%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000312069-26-000266
Form type
SCHEDULE 13G/A
Filer
Cartesian Therapeutics, Inc.
CIK
CIK 1453687
Filed
Nov 06, 2026
Reporting period
Sep 30, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub